Krystal Beily created a new blog entry
on December 27 2023 at 03:47 AM public
CMC Regulatory Considerations for ADCs
Antibody drug conjugates (ADCs)are a new class of biopharmaceuticals that use monoclonal antibodies to target tumor cells to deliver potent cytotoxic drugs. So far, a total of 15 ADC drugs have...